Scott Paulson, MD
Rapid advancements in understanding the biology of neuroendocrine tumors (NETs) has made this a thrilling time to be an oncologist in this field, according to Scott Paulson, MD.
In an interview during the meeting, Paulson highlighted developments with NETs and liver cancer that community oncologists should keep in mind moving forward.
OncLive: Can you provide an overview of your presentation on NETs?
There have been quite a few drug approvals coming through and a lot of positive trials. It’s starting to change the landscape about how we think about this as, classically, a very surgical, interventional radiology (IR)-based disease.
... to read the full story